With more than 70 years of neuroscience expertise, Lundbeck has developed and commercialized some of the world’s most widely prescribed therapies for brain diseases. Behind the science lies dedicated researchers, novel ideas, and a passion to make a difference.
Research & Development
Research and Development of new and improved treatments is at the core of what we do. We have state-of-the-art research centers in Denmark and California, US, and more than 800 employees work in our units.
Our pipeline reflects our goal to deliver novel therapies that redefine the standard of care for patients and address the areas in brain disease where we see the greatest need.
Lundbeck registers clinical trial protocols and discloses the results of clinical trials, regardless of outcome in a publicly-accessible trial registry.
We provide evidence-based medical education and training for healthcare professionals via the Lundbeck Institute and the Progress in Mind Resource Centre.
